CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Millenia Hope Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Millenia Hope Inc
SUITE 2200, 1250 RENE LEVESQUE WEST
Phone: (514) 846-5757p:514 846-5757 MONTREAL, QC  H3B 4W8  Canada Fax: (514) 251-7555f:514 251-7555
On 9/18/2013, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Millenia Hope Inc for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.
Business Summary
Millenia Hope Inc is a biopharmaceutical company based in Canada. It develops pharmaceuticals that are used in the treatment of parasitic disease, particularly malaria, as well as viral infections, such as acquired immune deficiency syndrome (AIDS), and other viral and bacterial infectious diseases. The Company’s main product is MMH Malarex/ MMH 18, an anti-malarial drug.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/28/201311/30/2007YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director LeonardStella 51
Chief Operating Officer, Director YehudaKops 58
Chief Scientific Officer SoribaCisse 56 1/5/2009
Vice President - Operations JeffreyBrooks 62

General Information
Number of Employees: 8 (As of 12/31/2007)
Outstanding Shares: 55,202,000 (As of 2/28/2013)
Shareholders: 2,000
Stock Exchange: OTC
Federal Tax Id: 980213828
Fax Number: (514) 251-7555


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023